Chengdu Shengnuo is one of the leading peptide manufacturers in China. There are 5 US-DMF of Peptide APIs:  Liraglutide, Bivalirudin, Eptifibatide, Icatibant and Octreotide. The below US-DMFs will be submitted soon: Linaclotide, Degarelix,  Teriparatide,Ziconotide,Exenatide and Ganirelix  soon. Shengnuo also have a few Chinese GMP APIs: Atosiban,Carbetocin, Octreotide, Enfuvirtide,Thymalfasin, Somatostatin, Thymopentin and Levosimendan.Chengdu Shengnuo Biopharm Co Ltd is a subsidiary of Chengdu Shengnuo Tech Development Co Ltd and was founded in October 2004. With 50 key technologies for large-scale production of domestic and foreign peptide drugs, we are a leading manufacturer of peptides by solid-phase chemistry. In addition, our team has the ability to perform product development, technology transfer, technical services and large-scale multi-kilogram single batch production capacities. As an industry leader in the domestic solid-phase peptide market, we have recently received approval as a registered US FDA manufacturing facility with zero...

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Contact information

Address

Telephone

Website

View All Contact Info

Top Products

Bivalirudin

Bivalirudin

Chengdu Shengnuo Biopharm Co Ltd

Icatibant

Icatibant

Chengdu Shengnuo Biopharm Co Ltd

Liraglutide

Liraglutide

Chengdu Shengnuo Biopharm Co Ltd

Categories affiliated with Chengdu Shengnuo Biopharm Co Ltd